Welcome to Acta Pharmacologica Sinica

APS, China's leading journal in pharmacology, encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

Free online issue

Volume 30, No 1
January 2009

ISSN: 1671-4083
EISSN: 1745-7254

2007 impact factor 1.677*
40/127 (Chemistry, Multidisciplinary);
129/205 (Pharmacology & Pharmacy)

Editor-in-Chief:
Jian Ding

* Journal Citation Reports, Thomson Reuters 2008

NEWS

Editor's Choice

Spanning a range of topics from bioengineering to neuropharmacology, cardiovascular pharmacology, cancer chemoprevention research and calcium signaling, APS is proud to present a collection of top review articles from recent years, as chosen by the editor. Complementing this collection, the January issue also includes the latest reviews covering various aspects of pharmacology.

New to NPG

From January 2009, Nature Publishing Group begins publishing APS, China's leading journal in pharmacology, in association with the Shanghai Institute of Materia Medica.

Extra navigation

7 January 2009

naturejobs

natureproducts


ADVERTISEMENT